Ann: BOT Submits FDA New Drug Application for Sofpironium Bromide, page-33

Yes but through another company with similar agreement relating to royalties, no?

maybe for them, it was more worthwhile to attain 9m and complete some other studies knowing that another company like BOT could raise funds attain FDA approval and then eventually into a manufacturing deal in the hopes of getting royalties in the future to further drive more research into what ever else they're doing

It wouldn't be a bad bet to buy some shares in Brickell Biotech Inc, because once we get approval, their share price should naturally increase.. No different to what we saw today with CGS getting up 36% (60% at one point) because a company that uses their software had some great results relating to "the news that Eisai’s Alzheimer treatment drug Lecanemab “met the primary endpoint and reduced clinical decline… by 27%.”